Maze TherapeuticsMAZE stock crashed Wednesday despite "overwhelmingly positive" test results for a kidney disease drug that could take on Vertex PharmaceuticalsVRTX. The biotech company tested its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results